How to taper off GLP-1 medication safely

There is no universal taper schedule, and what is right for you depends on your dose, how long you have been on the medication, your weight goal, your comorbidities, and your prescriber. The protocol below is illustrative. It is the kind of pattern that shows up in real-world endocrinology practice and patient forums, not a clinical guideline. Bring it to your doctor as a starting point, not as a plan.

A common pattern looks like this. Hold your current dose for two to four weeks while you write down your maintenance plan: protein target, training schedule, weighing cadence, and a personal weight threshold for restarting. Step down one dose and hold for another three to four weeks while you watch hunger ratings, weight, and protein intake. Step down again to the second-lowest dose and hold for three to four weeks. Then either stop, or, if hunger and weight are still under control, stop here. The whole process from full dose to stopped takes most people roughly two to four months.

The specifics vary by medication. Semaglutide steps are 2.4, 1.7, 1.0, 0.5, and 0.25 milligrams weekly. Tirzepatide steps are 15, 12.5, 10, 7.5, 5, and 2.5 milligrams weekly. Holding at a lower dose for longer is generally better tolerated than rushing the step-down. Some people skip the lowest dose if they were never titrated through it. None of this is a substitute for a conversation with your prescriber, who has access to your history and can adjust based on how you respond.

Appetite returns first. Most people notice it in the second or third week off the medication, sometimes earlier if you stopped from a low dose, sometimes later if you tapered slowly. The first signal is usually a meal that does not feel as satisfying as it used to, or a snack you would have skipped a month ago suddenly looking interesting. That is normal. It is the suppression fading, not a failure of willpower.

Food noise comes back over weeks, not hours. The mental chatter about food, the planning of the next meal, the cravings that show up unbidden, was quiet on the drug. It returns gradually, often peaking around weeks four to eight, then settling into a baseline that depends on your habits, sleep, stress, and whether you are at a calorie deficit.

Weight bounces in the first two weeks even before any real fat regain. Some of that is water. GLP-1s slow gastric emptying, so your gut holds less when the drug is gone, and stored glycogen rebinds water as you eat more carbs. A two to four pound bounce is common and not real fat. Real regain, if it happens, builds slowly across the next several months.

Fasting glucose may rise, especially in users who took GLP-1 for type 2 diabetes or prediabetes. This is the metabolic effect of the drug fading, not a new problem. If you have a glucose meter or a continuous glucose monitor, this is a moment to use it. GI side effects, the nausea, constipation, or reflux some users had on the drug, fade within a couple of weeks.

Four patterns matter more than any single number. Weight rebound speed: a slow drift of half a pound a week is fine and often water. Two pounds a week sustained for three weeks is a real signal. Hunger spikes: a daily one-to-five hunger rating on the same scale at the same time, averaged across the week, catches climbing hunger one to two weeks earlier than your scale will. Sleep quality: short sleep raises ghrelin and lowers leptin, so a hungrier you eats more, and the maintenance window is the worst time to be sleeping six hours. Mood and food noise: keep an eye on whether food is taking up more mental space than it did a month ago, because that is the earliest warning that something is drifting.

These are exactly the patterns Phaze's Taper Coach was built to surface. It cross-checks your daily weight, hunger ratings, protein, and sleep, and pings you a quiet note when one of them turns. Not an alarm, more like a careful friend who actually reads your numbers each day. If protein quietly slipped two weeks ago and weight starts climbing now, Taper Coach links them so you fix the cause, not the symptom.

Both are reasonable. The published data on cycling and maintenance dosing is thin because trials were designed around continuous full-dose treatment, but real-world endocrinology practice has converged on a few patterns. A maintenance dose, often the second-lowest, holds weight stable for many people with fewer side effects than the full weight loss dose. It is the closest analog to how blood pressure medication is used long-term.

Restarting after a clean stop also works. Pharmacologically, semaglutide and tirzepatide reach steady state again over four to six weeks, and many people see the appetite suppression return, though sometimes a notch weaker than the first round. Insurance coverage, side effect history, and whether you tolerated the original titration all factor in.

What does not work is unstructured cycling. Stopping cold, regaining, restarting, regaining again, repeated, is the strategy with the worst documented outcomes. The choice between restart and maintenance dose belongs with your prescriber, ideally with weight, protein, and habit data from the months around your stop in front of them.

The maintenance work is the same whether you stop, drop to a maintenance dose, or cycle. Hit a protein target around 0.8 to 1.0 grams per pound of bodyweight per day, spread across three or four meals. Lift weights two or three times a week, full body, focused on compound movements. Weigh daily on the same scale at the same time and track the seven day rolling average instead of the daily number. Sleep at least seven hours. Drink water roughly equal to half your bodyweight in pounds, expressed as ounces.

This stack is the same one in the keep weight off after GLP-1 guide for a reason. The biology of holding a loss is the biology of holding a loss, whether the medication is in your system, at a lower dose, or gone entirely. Phaze tracks each of these on one screen, so the stack stays visible even on the days you do not want to look.

Phaze's Taper Coach is built for this exact window. It watches your daily weight, hunger ratings, protein, and sleep, and surfaces a quiet nudge when one of them turns. Pattern detection cross-references the four metrics over weeks, so a rising weight at week eight gets traced back to the protein dip at week six and the sleep drop at week five, instead of being treated as a single problem. Smart warnings fire before risky drops, faster-than-planned weight loss during a step-down, sudden hunger climbs, or stalled progress that signals the taper is moving too fast. Everything runs locally on your device. Hunger ratings, weights, and notes are AES-256-GCM encrypted on device and in iCloud backup, never used for analytics or AI training.

For the longer arc, the Phaze Taper Coach feature page walks through the full set of pattern checks, smart warnings, and the export PDF you can bring to your prescriber. Pair it with the Phaze Lab Tracker so your fasting glucose and lipid trends sit next to your weight and protein, on one screen, in one place. The point of all this is not to replace your doctor. It is to make the conversation in the next visit a much better one.

Three questions are worth bringing into the appointment when you are considering stopping. First, what is the right step-down schedule for me, given my dose, how long I have been on it, my BMI, and my comorbidities. There is no universal answer, and your prescriber's recommendation matters more than any internet protocol. Second, what is the trigger to come back on, or to drop to a maintenance dose. A weight regain threshold, a glucose drift, a return of food noise, or an A1C number, getting that written down before you stop turns a vague intention into a real plan. Third, what bloodwork should I run during the first six months off, A1C, lipids, fasting glucose at minimum, so we can see whether the metabolic gains are holding.

Bring your weight, protein, and habit data into the visit. A clinician with three months of trend data makes better calls than one with a single in-clinic weight, and the time saved on data review is time spent on the actual decision. The deeper guide on keeping weight off after stopping GLP-1 covers the maintenance plan in more depth, and is worth reading before your appointment, not after.